These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32452414)

  • 1. Microbiota-independent antiviral effects of antibiotics on poliovirus and coxsackievirus.
    Woods Acevedo MA; Pfeiffer JK
    Virology; 2020 Jul; 546():20-24. PubMed ID: 32452414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Related Enteric Viruses Have Different Requirements for Host Microbiota in Mice.
    Robinson CM; Woods Acevedo MA; McCune BT; Pfeiffer JK
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Antibiotic Neomycin Enhances Coxsackievirus Plaque Formation.
    Woods Acevedo MA; Erickson AK; Pfeiffer JK
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30787120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Bacterial Cell Wall Components Influence the Stability of Coxsackievirus B3.
    Dhalech AH; Fuller TD; Robinson CM
    J Virol; 2021 Oct; 95(22):e0142421. PubMed ID: 34431699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota promote enteric virus replication and systemic pathogenesis.
    Kuss SK; Best GT; Etheredge CA; Pruijssers AJ; Frierson JM; Hooper LV; Dermody TS; Pfeiffer JK
    Science; 2011 Oct; 334(6053):249-52. PubMed ID: 21998395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride inhibits the initiation of Coxsackievirus and poliovirus RNA replication by inhibiting VPg uridylylation.
    Ogram SA; Boone CD; McKenna R; Flanegan JB
    Virology; 2014 Sep; 464-465():87-97. PubMed ID: 25058507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-Dependent Intestinal Replication of an Enteric Virus.
    Robinson CM; Wang Y; Pfeiffer JK
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and Indirect Effects on Viral Translation and RNA Replication Are Required for AUF1 Restriction of Enterovirus Infections in Human Cells.
    Ullmer W; Semler BL
    mBio; 2018 Sep; 9(5):. PubMed ID: 30181254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
    Wang Y; Pfeiffer JK
    mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
    Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model.
    Dhalech AH; Corn CM; Mangale V; Syed F; Condotta SA; Richer MJ; Robinson CM
    J Virol; 2022 Sep; 96(17):e0123222. PubMed ID: 36037480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Coxsackievirus B3 Infection in Pancreatic Ductal Cells
    Mastrodomenico V; LoMascolo NJ; Firpo MR; Villanueva Guzman MDM; Zaporowski A; Mounce BC
    mSphere; 2023 Jun; 8(3):e0003623. PubMed ID: 37097178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice.
    Pang J; Guo JP; Jin M; Chen ZQ; Wang XW; Li JW
    Chin J Integr Med; 2011 Oct; 17(10):764-9. PubMed ID: 21717161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
    Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
    PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a Glycan Library Reveals a New Model for Enteric Virus Oligosaccharide Binding and Virion Stabilization.
    Lu H; Lehrman MA; Pfeiffer JK
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral agents against picornaviruses.
    Eggers HJ
    Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
    [No Abstract]   [Full Text] [Related]  

  • 18. Deletions within the 5'UTR of coxsackievirus B3: consequences for virus translation and replication.
    Hunziker IP; Cornell CT; Whitton JL
    Virology; 2007 Mar; 360(1):120-8. PubMed ID: 17084431
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.